FROnTHERA

The main of objective of FROnTHERA is to boost the progress of Tissue Engineering and Regenerative Medicine fields with main focus on cancer, diabetes and neurodegenerative diseases. To accomplish this, the merge of 3D tissue engineered in vitro models of diseases, microfluidics, nanotechnologies, molecular biology and embedded biosensors will be pursued in order to obtain new tools and technologies to be used as alternative to animal experimentation, as well as, personalized therapies for Human health. Ultimately, the strengthening of these interdisciplinary domains will allow the improvement of theranostics of RIS3 diseases. This project is an initiative of three top leading research units, located in the PT 11 region, and gathers experts in tissue engineering in vitro models, neurosciences and emergent technologies based on responsive biosensors, whose main goal is to dvance in research for developing tools and technologies to be used as alternative to animal experimentation and in personalised therapies for human health.